MedTrace Logo

Pilot Study To Evaluate Optical Frequency Domain Imaging For Diagnosis Of Central Airway Disease

NCT00784329 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-03-12

No results posted yet for this study

Summary

To evaluate the potential of a new imaging device, termed Optical Frequency Domain Imaging (OFDI), in the early diagnosing of pulmonary malignancies in the central airways.

Conditions

  • Squamous Cell Lung Cancer
  • Lung Cancer
  • Pulmonary Disease

Interventions

DEVICE

Optical Frequency Domain Imaging (OFDI) System

Optical Frequency Domain Imaging(OFDI)System. Additional biopsy obtained from regions of normal appearing tissue. Up to an additional 20 minutes to standard Bronchoscopy

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • Lahey Clinic

    lead OTHER

Principal Investigators

  • Carla R Lamb, M.D. · Lahey Clinic, Inc.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00784329 on ClinicalTrials.gov